動物免疫診斷市場規模、佔有率、成長分析、按產品、按技術、按動物類型、按疾病類型、按最終用戶、按地區 - 行業預測，2025 年至 2032 年

2023 年全球獸醫免疫診斷市場價值為 27 億美元，預計將從 2024 年的 29.2 億美元成長到 2032 年的 54.4 億美元，預測期內（2025-2032 年）的複合年成長率為 8.1%。

獸醫免疫診斷市場正在經歷強勁成長，這歸因於多種因素，包括動物疾病的流行、疾病特異性免疫診斷測試的出現以及診斷技術的進步。寵物擁有量的快速成長以及對動物性食品的需求不斷成長進一步推動了這種擴張。儘管發展中國家缺乏獸醫診斷基礎設施，但新興經濟體仍提供了巨大的成長機會。正在進行的 COVID-19 疫情提高了人類和動物的檢測率，迫使實驗室創新動物檢測解決方案。儘管美國獸醫協會和疾病預防控制中心等組織不建議對動物進行常規 COVID-19 檢測，但衛生官員可能會根據不斷變化的情況做出決定，這凸顯了獸醫和衛生官員之間合作的重要性。

目錄

介紹

• 調查目的
• 研究範圍
• 定義

調查方法

• 資訊採購
• 次要和資料資料
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分市場機會分析

市場動態及展望

• 市場概況
• 市場規模
• 市場動態
  • 促進因素和機遇
  • 限制與挑戰
• 波特的分析

主要市場考察

• 關鍵成功因素
• 競爭程度
• 主要投資機會
• 市場生態系統
• 市場吸引力指數（2024 年）
• PESTEL 分析
• 總體經濟指標
• 價值鏈分析
• 定價分析

動物免疫診斷藥物市場規模（按產品）

• 市場概況
• 耗材
• 裝置

動物免疫診斷藥物市場規模（依技術分類）

• 市場概況
• 臨床生物化學
• 臨床化學分析
• 臨床化學試劑夾和試劑盒
• 臨床化學分析儀
• 血糖監測
  • 血糖值測試紙
  • 血糖值監測儀
  • 尿糖測試紙
  • 血氣和電解質分析
• 血氣電解質試劑夾盒
  • 血糖值監測儀
• 血氣電解質分析儀
• 分子診斷
  • 聚合酵素鏈鎖反應（PCR）檢測
  • 微陣列
  • 核酸序列分析
  • 其他分子診斷產品
• 血液學
  • 血液學試劑盒
  • 血液分析儀
• 尿液檢查
  • 尿液檢查夾和試劑盒/板
  • 尿液分析儀
  • 尿液檢查
• 免疫診斷
  • 橫向流動化驗
  • 快速側流檢測
  • 橫向流動試紙條讀取器
  • ELISA 檢測
  • 過敏特異性免疫診斷測試
  • 免疫檢測分析儀
  • 免疫檢測
  • 其他免疫診斷產品
• 其他獸醫診斷技術

動物免疫診斷藥物市場規模（以動物類型）

• 市場概況
• 伴同性動物
• 狗
• 貓
• 馬
• 家畜
• 牛
• 豬
• 家禽
• 其他牲畜

動物免疫診斷藥物市場規模（依疾病類型）

• 市場概況
• 感染疾病
• 細菌感染
• 病毒感染
• 寄生蟲感染
• 其他感染疾病
• 內分泌系統
• 瘤
• 心臟病
• 其他

動物免疫診斷藥物市場規模（按最終用戶分類）

• 市場概況
• 獸醫參考實驗室
• 獸醫診所
• 照護現場/內部偵測
• 獸醫研究機構和大學

獸用免疫診斷藥物市場規模

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲國家
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前 5 家公司對比
• 主要企業市場定位（2024年）
• 主要市場參與者所採用的策略
• 近期市場趨勢
• 公司市場佔有率分析（2024 年）
• 主要企業簡介
  • 公司簡介
  • 產品系列分析
  • 按細分市場分析市場佔有率
  • 收益與前一年同期比較（2022-2024 年）

主要企業簡介

• IDEXX Laboratories, Inc.（USA）
• Zoetis Inc.（USA）
• Thermo Fisher Scientific Inc.（USA）
• bioMerieux SA（France）
• Heska Corporation（USA）
• NEOGEN Corporation（USA）
• Bio-Rad Laboratories, Inc.（USA）
• Virbac（France）
• FUJIFILM Holdings Corporation（Japan）
• Shenzhen Mindray Bio-Medical Electronics Co., Ltd.（China）
• INDICAL BIOSCIENCE GmbH（Germany）
• BioNote, Inc.（South Korea）
• Biogal Galed Labs（Israel）
• Agrolabo SpA（Italy）
• IDvet（France）
• Randox Laboratories Ltd.（UK）
• BioChek（Netherlands）
• Biopanda Reagents（UK）
• URIT Medical Electronic Co., Ltd.（China）
• Bionote, Inc.（South Korea）

結論和建議

Global Veterinary Immunodiagnostics Market size was valued at USD 2.7 billion in 2023 and is poised to grow from USD 2.92 billion in 2024 to USD 5.44 billion by 2032, growing at a CAGR of 8.1% during the forecast period (2025-2032).

The veterinary immunodiagnostics market is experiencing robust growth driven by several factors, including the increased prevalence of animal diseases, the advent of disease-specific immunodiagnostic tests, and advancements in diagnostic technology. A surge in pet ownership and rising demand for animal-derived food products further fuel this expansion. Emerging economies present significant growth opportunities, despite challenges posed by inadequate veterinary diagnostic infrastructure in developing regions. The ongoing COVID-19 pandemic has heightened testing rates for both humans and animals, compelling laboratories to innovate animal testing solutions. Although organizations like the AVMA and CDC do not endorse routine COVID-19 testing for animals, the decision may be prompted by health officials based on evolving circumstances, underscoring the importance of collaboration between veterinarians and health authorities.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Veterinary Immunodiagnostics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Veterinary Immunodiagnostics Market Segmental Analysis

Global Veterinary Immunodiagnostics Market is segmented by Product, Technology, Animal Type, Disease Type, End User and region. Based on Product, the market is segmented into Consumables and Instruments. Based on Technology, the market is segmented into Clinical Biochemistry, Molecular Diagnostics, Hematology, Urinalysis, Immunodiagnostics and Other Veterinary Diagnostic Technologies. Based on Animal Type, the market is segmented into Companion Animals and Livestock. Based on Disease Type, the market is segmented into Infectious Disease, Endocrinology, Oncology, Cardiology and Others. Based on End User, the market is segmented into Veterinary Reference Laboratories, Veterinary Hospitals & Clinics, Point-of-care/ In-house Testing and Veterinary Research Institutes & Universities. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Veterinary Immunodiagnostics Market

The Global Veterinary Immunodiagnostics market is significantly driven by the potential transmission of serious zoonotic illnesses from animals to humans. At least 30 major diseases, including rabies, leptospirosis, and zoonotic tuberculosis, can spread through livestock and companion animals such as dogs and cats. The increasing prevalence of transboundary diseases, exemplified by foot-and-mouth disease affecting a large portion of livestock globally, further underscores the need for effective immunodiagnostic tools. Additionally, the emergence of zoonotic sources such as those linked to the COVID-19 pandemic highlights the critical role veterinary diagnostics play in safeguarding public health and preventing future outbreaks, ultimately fostering market growth.

Restraints in the Global Veterinary Immunodiagnostics Market

The Global Veterinary Immunodiagnostics market faces significant restraints due to the rising costs associated with pet care over the last decade. Research indicates that veterinary care represents the second-largest spending category within the pet care industry, with the U.S. alone contributing over $18.11 billion, marking a 6.1% increase from the previous year. High-end veterinary procedures can range from $5,000 to $20,000, while typical diagnostic costs for assessing antimicrobial resistance or infections using advanced techniques like PCR are notably steep. The reliance on expensive materials and cutting-edge technologies for treatments makes pet owners and veterinarians reluctant to invest heavily in diagnostic services.

Market Trends of the Global Veterinary Immunodiagnostics Market

The Global Veterinary Immunodiagnostics market is poised for significant growth, driven by the rising prevalence of zoonotic and vector-borne diseases linked to climate change, habitat modification, and evolving social dynamics. As these diseases become more common, there is an increasing need for rapid and precise diagnostic tools, particularly in companion animal medicine in developed countries. This trend is further fueled by a growing preference for advanced diagnostic technologies, such as RT-PCR, over traditional methods. Consequently, veterinary immunodiagnostics will play a critical role in disease management and prevention, positioning itself as a vital segment within the broader veterinary diagnostics market.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Veterinary Immunodiagnostics Market Size by Product & CAGR (2025-2032)

• Market Overview
• Consumables
• Instruments

Global Veterinary Immunodiagnostics Market Size by Technology & CAGR (2025-2032)

• Market Overview
• Clinical Biochemistry
• Clinical Chemistry Analysis
• Clinical Chemistry Reagent Clips & Cartridges
• Clinical Chemistry Analyzers
• Glucose Monitoring
  • Blood Glucose Strips
  • Glucose Monitors
  • Urine Glucose Strips
  • Blood Gas & Electrolyte Analysis
• Blood Gas And Electrolyte Reagent Clips and Cartridges
  • Glucose Monitors
• Blood Gas & Electrolyte Analyzers
• Molecular Diagnostics
  • Ploymerase Chain Reaction (PCR) Tests
  • Microarrays
  • Nucleic Acid Sequencing
  • Other Molecular Diagnostic Products
• Hematology
  • Hematology Cartridges
  • Hematology Analyzers
• Urinalysis
  • Urinalysis Clips & Cartridges/Panels
  • Urine Analyzers
  • Urine Test Strips
• immunodiagnostics
  • Lateral Flow Assays
  • Lateral Flow Rapid Tests
  • Lateral Flow Strip Readers
  • ELISA Tests
  • Allergen-specific Immunodiagnostic Tests
  • Immunoassay Analyzers
  • Radioimmunoassay
  • Other Immunodiagnostic Products
• Other Veterinary Diagnostic Technologies

Global Veterinary Immunodiagnostics Market Size by Animal Type & CAGR (2025-2032)

• Market Overview
• Companion Animals
• Dogs
• Cats
• Horses
  • Other Companion Animals
• Livestock
• Cattle
• Pigs
• Poultry
• Other Livestock

Global Veterinary Immunodiagnostics Market Size by Disease Type & CAGR (2025-2032)

• Market Overview
• Infectious Disease
• Bacterial Infection
• Viral Infection
• Parasitic Infection
• Other Infection
• Endocrinology
• Oncology
• Cardiology
• Others

Global Veterinary Immunodiagnostics Market Size by End User & CAGR (2025-2032)

• Market Overview
• Veterinary Reference Laboratories
• Veterinary Hospitals & Clinics
• Point-of-care/ In-house Testing
• Veterinary Research Institutes & Universities

Global Veterinary Immunodiagnostics Market Size & CAGR (2025-2032)

• North America (Product, Technology, Animal Type, Disease Type, End User)
  • US
  • Canada
• Europe (Product, Technology, Animal Type, Disease Type, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Technology, Animal Type, Disease Type, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Technology, Animal Type, Disease Type, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Technology, Animal Type, Disease Type, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• IDEXX Laboratories, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Zoetis Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• bioMerieux SA (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Heska Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• NEOGEN Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Virbac (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• FUJIFILM Holdings Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• INDICAL BIOSCIENCE GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BioNote, Inc. (South Korea)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biogal Galed Labs (Israel)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agrolabo S.p.A. (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• IDvet (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Randox Laboratories Ltd. (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BioChek (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biopanda Reagents (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• URIT Medical Electronic Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bionote, Inc. (South Korea)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations